HLA-DR and -DQ associations with multiple sclerosis in Turkey

被引:80
|
作者
SaruhanDireskeneli, G
Esin, S
BaykanKurt, B
Ornek, I
Vaughan, R
Eraksoy, M
机构
[1] UNIV ISTANBUL,ELECTRONEUROPHYSIOL RES & APPLICAT CTR,ISTANBUL,TURKEY
[2] UNIV ISTANBUL,FAC MED,DEPT PHYSIOL,ISTANBUL,TURKEY
[3] UNIV ISTANBUL,FAC MED,DEPT NEUROL,ISTANBUL,TURKEY
[4] GUYS HOSP,LONDON SE1 9RT,ENGLAND
关键词
GENETIC SUSCEPTIBILITY; HLA-DQA1; ALLELES; CHAIN;
D O I
10.1016/S0198-8859(97)00086-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The DRB, DQA, and DQB subregions of the major histocompatibility complex (MHC) were investigated by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization (PCR/SSO) in 103 multiple sclerosis (MS) patients and 101 healthy controls from Turkey. Significant differences were detected between MS and control populations in the frequencies of DRB1*1501 [29 vs. 14, p = 0.02, odds ratio (OR) = 2.4], DRB1*04 (35 vs. 18, p = 0.01, OR = 2.3), DQB1*0302 (30 vs. 15, p = 0.02, OR = 2.3), DQB1*0602 (27 vs. 10, p = 0.005, OR = 3.2), DQB1*0501 (10 vs. 24, p = 0.01, OR = 0.3), DQA1*0101 (16 vs. 31, p = 0.02, OR = 0.4), and DQA1*0103 (7 vs. 19, p = 0.02, OR = 0.3). These results confirm the proposed positive association of the Dw2. (DRB1*1501 DQA1*0102 DQB1*0602) haplotype with MS in Caucasians in our Turkish population (25 vs. 8, p = 0.003, OR = 3.7). Furthermore, the ''putative'' haplotype supposed to be more frequent in the MS population of Mediterranean countries, namely DRB1*04 DQA1*03 DQB1*0302, is also associated with MS in Turkey (29 vs. 12, p = 0.006, OR = 2.9). The presence of two different haplotypic associations in MS emphasizes the complexity of the genetic susceptibility to MS in different populations. (C) American Society for Histocompatibility and Immunogenetics, 1997. Published by Elsevier Science Inc.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [1] HLA-DR and -DQ associations with melioidosis
    Dharakul, T
    Vejbaesya, S
    Chaowagul, W
    Luangtrakool, P
    Stephens, HAF
    Songsivilai, S
    HUMAN IMMUNOLOGY, 1998, 59 (09) : 580 - 586
  • [2] MULTIPLE-SCLEROSIS AND HLA - IS THE SUSCEPTIBILITY GENE REALLY HLA-DR OR -DQ
    FRANCIS, DA
    THOMPSON, AJ
    BROOKES, P
    DAVEY, N
    LECHLER, RI
    MCDONALD, WI
    BATCHELOR, JR
    HUMAN IMMUNOLOGY, 1991, 32 (02) : 119 - 124
  • [3] HLA-DR, DQ, AND DX ALPHA-RFLPS AND THEIR ASSOCIATIONS WITH SEROLOGICALLY DEFINED HLA-DR AND HLA-DQ ANTIGENS
    AWAD, J
    NAVARRETE, C
    SACHS, JA
    FESTENSTEIN, H
    CASSELL, PG
    NIVEN, MJ
    HITMAN, G
    IMMUNOGENETICS, 1988, 27 (01) : 73 - 76
  • [4] HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey
    Saruhan-Direskeneli, G
    Uyar, FA
    Bas, F
    Günöz, H
    Bundak, R
    Saka, N
    Darendeliler, F
    HUMAN IMMUNOLOGY, 2000, 61 (03) : 296 - 302
  • [5] Mapping multiple sclerosis (MS) susceptibility to the HLA-DR and DQ loci in the Venezuelan population
    Armas, E
    Layrisse, Z
    Molina, O
    Montagnani, S
    Balbas, O
    Soublette, C
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S220 - S220
  • [6] Immune response of HLA-DQ, HLA-DR, and HLA-DR/DQ transgenic mice to ragweed allergen
    Chapoval, S
    Marietta, E
    Iijima, K
    Smart, M
    David, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S369 - S369
  • [7] HLA-DR AND HLA-DQ DNA GENOTYPING IN MULTIPLE-SCLEROSIS PATIENTS IN NORTHERN-IRELAND
    CULLEN, CG
    MIDDLETON, D
    SAVAGE, DA
    HAWKINS, S
    HUMAN IMMUNOLOGY, 1991, 30 (01) : 1 - 6
  • [8] FREQUENCY AND ASSOCIATIONS OF HLA-DR AND HLA-DQ ANTIGENS IN A BRITISH CAUCASOID PANEL
    AWAD, J
    NAVARRETE, C
    FESTENSTEIN, H
    TISSUE ANTIGENS, 1987, 29 (01): : 55 - 59
  • [9] HLA-DR and -DQ polymorphism in Cameroon
    Pimtanothai, N
    Hurley, CK
    Leke, R
    Klitz, W
    Johnson, AH
    TISSUE ANTIGENS, 2001, 58 (01): : 1 - 8
  • [10] THE INFLUENCE OF HLA-DR AND HLA-DQ ALLELES ON PROGRESSION TO MULTIPLE-SCLEROSIS FOLLOWING A CLINICALLY ISOLATED SYNDROME
    KELLY, MA
    CAVAN, DA
    PENNY, MA
    MIJOVIC, CH
    JENKINS, D
    MORRISSEY, S
    MILLER, DH
    BARNETT, AH
    FRANCIS, DA
    HUMAN IMMUNOLOGY, 1993, 37 (03) : 185 - 191